Information Provided By:
Fly News Breaks for March 10, 2015
BMY, RHHBY, PCYC, BAYRY, AZN, ABBV, GSK, LLY, PFE
Mar 10, 2015 | 08:08 EDT
Jefferies says AbbVie (ABBV) remains its Top Global Pick in Pharmaceuticals on its belief the Pharmacyclics (PCYC) deal will be an inflection point for the stock. Pfizer (PFE) remains the firm's second pick and AstraZeneca (AZN) third, with the latter being promoted to Top European Pick. Roche (RHHBY) is in the fourth spot and Eli Lilly (LLY) has been moved to fifth in place of Bayer (BAYRY) which dropped to eighth. Bristol-Myers (BMY) and GlaxoSmithKline (GSK) are Jefferies' least preferred stocks in the space.
News For ABBV;PCYC;PFE;AZN;RHHBY;LLY;BAYRY;BMY;GSK From the Last 2 Days
RHHBY
Mar 18, 2019 | 09:18 EDT
HBV Investor Summit will be held in New York on March 18.
PFE, BMY
Mar 18, 2019 | 09:17 EDT
DCAT Week 2019 will be held in New York on March 18-21.
AZN, BAYRY, PFE
Mar 18, 2019 | 08:56 EDT
68th Annual Scientific Sessions of the ACC will be held in New Orleans, LA on March 16-18 where some presentations may be webcasted. Webcast Link
AZN
Mar 18, 2019 | 06:20 EDT
AstraZeneca is preparing a big push into digital technologies, including hiring former Nasa artificial intelligence expert Richard Dearden, as it looks to ramp up drug discovery and show the value of its medicines in an increasingly tough pricing environment, the Financial Times' Sarah Neville reports, citing CEO Pascal Soriot. Soriot suggested Astra would seek to broaden the range of drugs it offered where payment was dependent on results achieved as such medicines could be part of reducing health costs overall. Reference Link
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.